InnoCare Pharma Limited (SHA:688428)

InnoCare Pharma Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	25,183	11,872	12,415	21,828	18,693	14,633
Market Cap Growth	98.27%	-4.38%	-43.12%	16.78%	27.74%	-
Enterprise Value	19,847	6,134	4,750	13,726	13,839	11,649
Last Close Price	25.12	12.28	11.50	14.11	-	-
PS Ratio	20.56	11.76	16.81	34.90	17.92	10727.94
PB Ratio	3.72	1.76	1.73	2.86	3.30	4.63
P/TBV Ratio	3.88	1.84	1.81	2.89	3.36	4.78
P/OCF Ratio	-	-	-	-	111.89	-
EV/Sales Ratio	16.54	6.08	6.43	21.95	13.27	8540.54
Debt / Equity Ratio	0.23	0.23	0.23	0.20	0.23	0.37
Asset Turnover	0.13	0.10	0.07	0.07	0.18	0
Inventory Turnover	1.40	1.29	1.39	3.81	11.13	-
Quick Ratio	7.32	7.01	4.13	4.43	19.29	38.75
Current Ratio	7.84	7.45	4.21	4.48	19.49	39.18
Return on Equity (ROE)	-4.24%	-6.50%	-8.71%	-13.44%	-1.51%	-368.36%
Return on Assets (ROA)	-2.63%	-3.52%	-4.15%	-5.48%	-1.91%	-9.77%
Return on Capital (ROIC)	-3.19%	-3.97%	-4.66%	-6.02%	-2.02%	-10.37%
Earnings Yield	-1.11%	-3.71%	-5.08%	-4.06%	-0.34%	-2.67%
FCF Yield	-1.16%	-3.74%	-7.41%	-3.63%	-0.01%	-2.89%
Buyback Yield / Dilution	7.72%	0.67%	-15.31%	-8.29%	-41.21%	-321.19%

Updated Nov 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.